A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis

Clinical trial NCT06999733 · RECRUITING

Trial details

NCT number: NCT06999733
Sponsor: Krystal Biotech, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neurotrophic Keratitis

Start date: 2025-07-07
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.